Kenvue (KVUE Quick QuoteKVUE - Free Report) reported $4 billion in revenue for the quarter ended June 2024, representing a year-over-year decline of 0.3%. EPS of $0.32 for the same period compares to $0.32 a year ago.

The reported revenue represents a surprise of +1.75% over the Zacks Consensus Estimate of $3.93 billion. With the consensus EPS estimate being $0.28, the EPS surprise was +14.29%.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how Kenvue performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

• Net Sales- Self Care

  : $1.64 billion compared to the $1.64 billion average estimate based on three analysts.

• Net Sales- Essential Health

  : $1.26 billion versus $1.23 billion estimated by three analysts on average.

• Net Sales- Skin Health and Beauty

  : $1.10 billion versus the three-analyst average estimate of $1.11 billion.

• Adjusted Operating Income- Self Care

  : $534 million versus the two-analyst average estimate of $558.98 million.

• Adjusted Operating Income- Essential Health

  : $359 million versus the two-analyst average estimate of $154.69 million.

• Adjusted Operating Income- Skin Health and Beauty

  : $165 million versus the two-analyst average estimate of $195.87 million.

View all Key Company Metrics for Kenvue here>>>

Shares of Kenvue have returned -0.3% over the past month versus the Zacks S&P 500 composite's -6.7% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.